
Insights from recent episode analysis
Audience Interest
Podcast Focus
Publishing Consistency
Platform Reach
Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.
Most discussed topics
Brands & references
Est. Listeners
Insufficient chart data. Estimates will improve as the show charts.
- Per-Episode Audience
Est. listeners per new episode within ~30 days
N/A🎙 ~2x weekly·100 episodes·Last published 1w ago - Monthly Reach
Unique listeners across all episodes (30 days)
N/A - Active Followers
Loyal subscribers who consistently listen
N/A
Market Insights
Platform Distribution
Reach across major podcast platforms, updated hourly
Total Followers
—
Total Plays
—
Total Reviews
—
* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.
On the show
From 15 epsHost
Recent guests
Recent episodes
178: Dale Atkinson survived Stage IV esophageal cancer | palliative care | endoscopy | CAPOX | cold neuropathy
Jun 13, 2026
27m 16s
177: Dr. Jessa Landmann provides care for cancer survivors in the post-treatment phase | naturopathy | complimentary therapies
Jun 3, 2026
17m 06s
176: Mike Fitzpatrick survived pancreatic cancer | whipple procedure | nanoknife | lanreotide | cancer cachexia
May 30, 2026
28m 06s
175: Michelle Reed survived bladder cancer | cystoscopy | gemcitabine | bcg immunotherapy | mitomychin
May 15, 2026
32m 15s
174: John Walker Pattison survived hodgkin lymphoma and bladder cancer | vincristine | prednisolone | mitomycin | cystoscopy
May 12, 2026
25m 10s
Social Links & Contact
Official channels & resources
Official Website
Login
RSS Feed
Login
| Date | Episode | Topics | Guests | Brands | Places | Keywords | Sponsor | Length | |
|---|---|---|---|---|---|---|---|---|---|
| 6/13/26 | ![]() 178: Dale Atkinson survived Stage IV esophageal cancer | palliative care | endoscopy | CAPOX | cold neuropathy✨ | cancer survivalpalliative care+4 | Dale Atkinson | palliative careCAPOX+1 | — | esophageal cancerpalliative care+6 | — | 27m 16s | |
| 6/3/26 | ![]() 177: Dr. Jessa Landmann provides care for cancer survivors in the post-treatment phase | naturopathy | complimentary therapies✨ | cancer survivorshipnaturopathy+3 | Dr. Jessa Landmann | — | — | cancersurvivors+6 | — | 17m 06s | |
| 5/30/26 | ![]() 176: Mike Fitzpatrick survived pancreatic cancer | whipple procedure | nanoknife | lanreotide | cancer cachexia✨ | pancreatic cancerWhipple Procedure+4 | Mike Fitzpatrick | Whipple Procedurenanoknife+2 | — | pancreatic cancerWhipple Procedure+3 | — | 28m 06s | |
| 5/15/26 | ![]() 175: Michelle Reed survived bladder cancer | cystoscopy | gemcitabine | bcg immunotherapy | mitomychin✨ | bladder cancerchemotherapy+4 | Michelle Reed | gemcitabineBCG immunotherapy+1 | — | bladder cancergemcitabine+5 | — | 32m 15s | |
| 5/12/26 | ![]() 174: John Walker Pattison survived hodgkin lymphoma and bladder cancer | vincristine | prednisolone | mitomycin | cystoscopy✨ | cancer survivalHodgkin lymphoma+3 | John Walker Pattison | vincristineprednisolone+1 | — | Hodgkin lymphomabladder cancer+5 | — | 25m 10s | |
| 4/29/26 | ![]() 173: Dr. Ben Evans is a colon cancer expert | colonoscopy | stool-based tests | rectal bleeding | polyps✨ | colon cancerscreening+4 | Dr. Ben Evans | Louisville-based gastroenterologist | — | colon cancerscreening age+5 | — | 19m 10s | |
| 4/23/26 | ![]() 172: Cindy Koerner survived breast cancer | epirubicin | zoladex | cyclophosphamide | estradiol✨ | breast cancerchemotherapy+3 | Cindy Koerner | epirubicinzoladex+2 | — | breast cancerchemotherapy+3 | — | 18m 27s | |
| 3/31/26 | ![]() 171: Hope Nightingale survived osteosarcoma | neoadjuvant chemotherapy | cisplatin | doxorubicin✨ | osteosarcomaneoadjuvant chemotherapy+3 | Hope Nightingale | cisplatindoxorubicin | — | osteosarcomaneoadjuvant chemotherapy+5 | — | 21m 42s | |
| 3/24/26 | ![]() 170: Jess survived myxopapillary ependymoma | pregabalin | duloxetine | spinal cord stimulator | lower lumbar✨ | cancer survivalspinal cord conditions+3 | Jess | pregabalinduloxetine+1 | — | myxopapillary ependymomaspinal cord tumor+3 | — | 26m 50s | |
| 3/14/26 | ![]() 169: Adam Deans survived osteosarcoma | bone cancer | distal femur | prosthetic leg✨ | osteosarcomabone cancer+5 | Adam Deans | Australian national teamParalympics+1 | Australia | osteosarcomabone cancer+5 | — | 34m 35s | |
Want analysis for the episodes below?Free for Pro Submit a request, we'll have your selected episodes analyzed within an hour. Free, at no cost to you, for Pro users. | |||||||||
| 3/8/26 | ![]() 168: Kevin Donaghy twice survived skin cancer | immunotherapy | pembroluzimab | metastatic melanoma✨ | skin cancerimmunotherapy+4 | Kevin Donaghy | pembroluzimab | Scotland | skin cancerimmunotherapy+5 | — | 19m 32s | |
| 2/27/26 | ![]() 167: Bob Schreiber survived bladder cancer | Cystoscopy | BCG | Ileal Conduit | Replacement Bladder | Neobladder✨ | bladder cancercystoscopy+3 | Bob Schreiber | urologistBCG+1 | — | bladder cancercystoscopy+3 | — | 25m 31s | |
| 2/20/26 | ![]() 166: Beth Lehman survived liver cancer | cirrhosis | heptacellular carcinoma | y-90 | hepatic encephalopathy | ascites✨ | liver cancercancer recovery+3 | Beth Lehman | hepatocellular carcinomabasal cell carcinoma+3 | — | liver cancercirrhosis+7 | — | 24m 14s | |
| 2/7/26 | ![]() 165: Athena Porter survived cervical cancer | radical hysterectomy | endocervical adenocarcinoma | HPV+✨ | cervical cancerHPV+4 | Athena Porter | Mayo ClinicIowa | — | cervical cancerHPV+5 | — | 22m 29s | |
| 1/23/26 | ![]() 164: Joshua Silva survived clear cell renal cell carcinoma | partial nephrectomy | appendectomy | kidney cancer✨ | kidney cancerhealth journey+4 | Joshua Silva | — | Houston, Texas | kidney cancerclear cell renal cell carcinoma+6 | — | 18m 00s | |
| 1/10/26 | ![]() 163: Tessa Parry-Wingfield survived Ocular Melanoma | Eye Enucleation | Uveal Melanoma | Monocular Vision | While jogging in 2023, Tessa Parry-Wingfield felt an unusual sensation in her left eye. It wasn't painful but merited medical attention. She was seen by three doctors before learning she had ocular melanoma, a form of eye cancer. Because of the particulars of her diagnosis, she had to undergo an enucleation, the removal of her cancerous eye. With an acrylic implant taking the place of the cancerous eye, Tessa had an enormous amount of learning ahead of her, most notably what is known as monocular vision. Amazingly, Tessa has adjusted to her limited vision. She has resumed running and hiking and driving a car. Her future includes writing a book and climbing Mt. Kilimanjaro. Tessa was jogging along the River Thames in London when she felt something was wrong with her left eye. She went to see an optician thinking she needed to change her prescription regarding her contact lenses. However, upon checking out Tessa's eyes, the optician could see something was wrong, perhaps an astigmatism. Lacking the necessary equipment for more in-depth scrutiny, the optician sent Tessa to an eye hospital, where they performed various x-rays and scans. When one of the x-rays of her left eye was held up for observation, half of it was black. Her care team thought Tessa had a form of eye cancer known as ocular melanoma, or, uveal melanoma, a tumor in the eye. She was next sent to see an ocular oncologist, who swiftly confirmed the diagnosis. Many patients diagnosed with ocular melanoma have more than one treatment option, but in Tessa Parry-Wingfield's case, the oncologist performed more scans and tests and immediately told her she would need to undergo an enucleation, the removal of her left eye. Tessa was under anesthesia for the 90-minute procedure. It resulted in her getting a temporary prosthetic eye, eventually replaced by an acrylic implant, which she has to this day. She had to do a great deal of learning to go through daily life with one functioning eye, but that is exactly what Tessa has done. She has resumed running, hiking and skiing. She thought it would be a year or so of adjustments before she could drive a car, but her vision tests went so well that, three months after the procedure, her oncologist urged her to get behind the wheel. Without a left eye, she says she has to look a little farther to the left than she was used to before her diagnosis, but she is now quite comfortable driving a car. Through her cancer experience, Tessa Parry-Wingfield says she has surprised herself by learning how tough and resilient she can be. Additional Resources: Tessa on Instagram: @seeing_life_clearly Tessa's website: https://www.tessa.parry-wingfield.com | — | ||||||
| 12/31/25 | ![]() 162: Bhavika Taunk cared for her son, diagnosed with leukemia | pediatric cancer | For Bhavika Taunk, life took a radical turn in 2017 when her four-year-old son, Kabir, was diagnosed with acute lymphoblastic leukemia. After a bone marrow transplant, he went on an aggressive chemotherapy regimen for two years. Kabir relapsed twice, but has been in remission since 2020. Bhavika tells the story of how she cared for her son and how she reaches out to other parents of children diagnosed with cancer. Bhavika, her husband and two young sons returned from a Disney cruise in April 2017, and both sons felt sick. While her two-year-old son soon got well, things went from bad to worse for four-year-old Kabir. He complained of bone pain, first in his wrists, then his ankles, to the extent that he could not walk. Then he suffered from intermittent fevers and appetite loss. Kabir was taken to a hospital, where after blood tests, Bhavika was told that a bad virus had settled into her son's bone marrow and that he had been diagnosed with acute lymphoblastic leukemia. She called her husband with the awful, collapsed on the floor and cried. Bhavika said this was the most life-changing event of her life. She went on to say the degree of helplessness accompanying such a diagnosis is overwhelming. Up until Kabir's diagnosis, she thought she could fix anything in his life that presented a challenge. Bhavika says the biggest lesson with a child's cancer diagnosis is the total lack of control and it is the worst imaginable feeling. Bhavika says when caring for a child with cancer that words are very important. She stresses that she doesn't believe in "hollow encouragement because it is very invalidating to the patient." She says a parent cannot tell their cancer-stricken child that everything is going to be okay. Kabir has been in remission since 2020, but still requires a great deal of attention and medical care. Bhavika Taunk wants very much to come to the aid of parents of a child diagnosed with cancer. She advocates for parents of Facebook and Instagram, while strenuously calling for increased funding for pediatric cancer patients. Additional Resources: Bhavika on Facebook: https://www.facebook.com/bhavika.v.taunk Bhavika on Instagram: https://www.instagram.com/btaunk/ Bhavika's small business supporting pediatric cancer: Birdsong Tea – Tea With A Purpose | — | ||||||
| 12/27/25 | ![]() 161: Brian Vesall survived Stage 2A testicular cancer | orchiectomy | bleomycin | etopside | cisplatin | teratoma | In 2021, Brian Vesall noticed some pain in one of his testicles when getting in his car. He sought medical attention, which led to his getting an ultrasound. After briefly looking at the scan, a urologist confirmed to Brian that he had Stage 2A testicular cancer. He underwent an orchiectomy to remove the cancerous testicle, followed by an aggressive chemotherapy regimen of bleomycin, etopiside and cisplatin. But he wasn't done. Brian also underwent an additional surgical procedure to remove approximately 30 lymph nodes. As daunting as his treatment was, Brian chose to address it with a sense of humor, which he still has after achieving survivorship and advocating for other men diagnosed with testicular cancer. Brian's cancer journey began when he felt pain in a testicle as he was getting in his car. Upon further inspection, he noticed a "hard spot on one side." He immediately went to see his primary physician, who sent him to a urologist. The urologist called for an ultrasound and only minutes after seeing its results told Brian he had Stage 2A testicular cancer. The diagnosis was confirmed with Alpha-Fetaprotein and BHCG, or, Human Chorionic Gonadotropin tests, whose results were far above the normal range. Addressing his cancerous testicle meant just one remedy, an orchiectomy, surgery that would remove the testicle. Diagnosed on September 27, 2021, Brian had the procedure done just three days later. He was told to avoid any lifting and really, just about any type of strenuous physical activity. In November 2021, the surgery was followed by three rounds of BEP chemotherapy, which stood for bleomycin, etopiside and cisplatin. Brian said he suffered the usual side effects, including cognitive issues, fatigue and hair loss. In addition, Brian Vesall had to undergo an additional surgical procedure known as RPLND, or Retroperitoneal Lymph Node Dissection in June 2022, to remove approximately 30 lymph nodes Brian's health is pretty much back to normal, but a byproduct of his treatment regimen is that he suffers from retrograde ejaculation, meaning that semen travels backward into the bladder during orgasm instead of exiting the penis. By way of advice, Brian Vesall says if you experience the symptoms of testicular cancer, you should act right away, and at all times, be your own advocate Additional Resources: Support Groups: Man Up To Cancer: https://www.manuptocancer.org The Testicular Cancer Awareness Foundation: https://www.testicularcancerawarenessfoundation.org Brian's Speech at TCAF's San Diego Conference: https://www.testicularcancerawarenessfoundation.org/blog/tcc-2024-vesall Brian's Appearance on the TCAF "It Takes Balls" podcast: https://www.testicularcancerawarenessfoundation.org/blog/brian-vesall-it-takes-balls-podcast-guest | — | ||||||
| 12/11/25 | ![]() 160: Marcel D'Allende survived Stage 4 Lung Cancer | carboplatin | pemetrexed | durvalumab | immunotherapy | Marcel D'Allende was in outstanding health, an avid hiker in the mountains overlooking her hometown of Cape Town, South Africa. However, in October 2021, she began to experience shortness of breath and extreme fatigue. That led to a diagnosis of Stage IV non-small cell adenocarcinoma, or lung cancer. Determined not to let cancer define her, she underwent a treatment regimen of radiotherapy, then chemotherapy with carboplatin and pemetrexed, and immunotherapy with durvalumab. In September 2022, a PET scan revealed Marcel was cancer-free. It took a little while for her to get back up to speed, but has returned to an active lifestyle, and every weekend, you can find her hiking the mountains. Marcel thought she was in terrific health, but in the fall of 2021, suddenly she found herself out of breath on a recurring basis. Her difficulty with breathing became so acute that shortly after beginning a weekend hike with friends, she had no choice but to turn around and return to the base of the mountain. Things worsened when she had frequent coughing spells. She was seen by her general practitioner, who recommended she see a pulmonologist. The pulmonologist called for a CT scan, which revealed a tumor on a lung, and a diagnosis of Stage IV lung cancer in January 2022. Marcel, who during her adult life smoked cigarettes off and on, immediately thought of her father, who passed away from lung cancer in 2000. She was afraid she would suffer the same fate. However, her doctor said that her father's fate didn't have to be hers because of major advances in medicines and technologies in the past twenty years. She was determined to not let her life be defined by cancer, saying at all times, one on a cancer journey must have hope. At the same time, she says one can be hopeful without being delusional. Her diagnosis was difficult enough, but she soon felt the sting of the stigma that often accompanies a lung cancer diagnosis. When informing friends about her diagnosis, many of them told her should not have smoked. Marcel's treatment begins with six weeks of radiotherapy treatment, which she thought wasn't so difficult. Next was six cycles of chemotherapy, specifically carboplatin and pemetrexed. The worst side effects she experienced were nausea and fatigue. Then, Marcel's oncologist introduced her to a newly-approved form of immunotherapy called durvalumab. It is usually prescribed for a duration of twelve months, but she was taken off the immunotherapy at the nine-month mark because spots were detected on her lung. The spots cleared in March. In September, Marcel D'Allende underwent a PET scan that showed she was cancer-free, which she has been to this day. She had to start slowly, but Marcel's health is back to normal, and she has returned to her weekend home, hiking trails outside Cape Town. Additional Resources: Support Group: Cancer Association of South Africa https://www.cansa.org.za Marcel's Written Account of her Cancer Journey: https://cansa.org.za/breaking-the-silence-around-lung-cancer/ | — | ||||||
| 12/4/25 | ![]() 159: Margo Wickersham survived bladder cancer | cystoscopy | radical cystectomy | plasmacytoid | In November 2019, Margo Wickersham noticed blood in her urine. Three months later, she was diagnosed with two types of bladder cancer. After an aggressive chemotherapy regimen, she underwent a radical cystectomy and a hysterectomy in June 2020, resulting in the removal of her bladder, uterus and ovaries, all this during the quarantine phase of the COVID pandemic. Ever since, Margo has been cancer-free, but she had to get fitted with a stoma bag and had to learn how to manage it. The bag is an annoyance, but she considers it a small price to pay in order to stay alive. When Margo first noticed blood in her urine, she sought medical attention, thinking she had a urinary tract infection. It turned out she didn't have a UTI, but she still thought something was wrong. She underwent a cystoscopy, which captured a photo of a cauliflower-shaped tumor in her bladder. Next up was a biopsy, which indicated she had Stage One bladder cancer. Her urologist prescribed BCG immunotherapy. Margo sought a second opinion and her doctor ruled out BCG, because further probing turned up a second type of bladder cancer, plasmacytoid, and said it could not be addressed with BCG. He called for an aggressive chemotherapy regimen. He also said in addition to a radical cystectomy, which would remove Margo's bladder, he said a hysterectomy would be necessary, a procedure that would remove her uterus and ovaries. Both were performed in June 2020. Because that was during the quarantine phase of the COVID pandemic, neither Margo's husband nor members of her family could visit her. After the procedures, Margo was cancer-free. However, her life would never be the same after she had to wear a stoma bag into which her urine would go. Sometimes the bag leaks when filled beyond its capacity. She accepts this as her new normal and says she can deal with it, but has to think ahead in terms of access to a bathroom. By way of advice, Margo says one's primary emotion should be that of hope and not stress. Additional Resources: Support Group: Bladder Cancer Advocacy Network https://www.bcan.org Margo's Book, available on Amazon and Kindle: Gratitude in the Storm – When Not Dying Is Enough to Keep Fighting Margo's merchandise line: www.ThriverSurvivor.shop, with a portion of the revenue going to the Bladder Cancer Advocacy Network, to fund bladder cancer research | — | ||||||
| 11/25/25 | ![]() 158: Casey Kang survived acute lymphoblastic leukemia | experimental immunotherapy | doxorubicin | methotrexate | When she began experiencing severe bruising and fatigue and turning pale in late 2013, Casey Kang sought medical attention. This led to a diagnosis of acute lymphoblastic leukemia. She was placed on an aggressive, 18-month chemotherapy regimen, which included doxorubicin and methotrexate. Casey relapsed three times during which she was placed on an experimental immunotherapy. All told, she spent 168 days in a hospital, but Casey achieved survivorship. She is now a coach who helps women diagnosed with cancer through the physical, mental and emotional challenges that occur after treatment. When Casey Kang experienced various aches and pains at the end of 2013, she thought they were tied to holiday- or work-related stress. She sought medical attention, was prescribed ten days of antibiotics, and was told to return in two weeks. During the ten days, things got worse. She was stricken with extreme fatigue, bruising, vision issues and her turning pale. While this went on, she continued to go to work. She underwent blood tests, and they revealed she had leukemia. Even before the test results came back, her care team called for a bone marrow transplant, so sure were they that she had cancer. Casey said her cancer was subsequently diagnosed as acute lymphoblastic leukemia. Because of its aggressive nature, she was put on an aggressive, 18-month chemotherapy regimen. It included doxorubicin and methotrexate. She experienced two relapses and was prescribed an experimental immunotherapy. Multiple hospital stays totaled 168 days. During that time, Casey learned how mentally tough she was and is. As much as she disliked the time in the hospital, she was sure to create a routine that would get her through the day. Casey used the hospital floor's exercise bike and walked laps around the floors, with 17 laps equaling a mile. Despite a grueling journey, Casey Kang achieved survivorship. She is active on social media, as she works tirelessly to aid woman diagnosed with cancer to make them physically, mentally and emotionally strong when dealing with life after treatment. As for herself, she says her overall is better than it was before her diagnosis. Additional Resources: Casey's Website: https://www.thehappierhustle.com Casey's Free Guide: https://casey-head.mykajabi.com/free-guide | — | ||||||
| 11/9/25 | ![]() 157: genetic testing helped stacy martin survive gastric cancer | prophylactic total gastrectomy | Stacy Martin says genetic testing saved her life. The testing indicated she had the CDH1 mutation. The mutation gave her an 80 percent chance of getting gastric cancer and a 60 percent chance of breast cancer. She opted for a prophylactic total gastrectomy to remove her stomach and addressed the possibility of breast cancer with a bilateral mastectomy. Without a stomach, Stacy has had to change the way she eats, requiring food every two hours, and having to completely chew everything she eats. Despite this live-changing surgery, Stacy is leading a healthy and happy life. Unlike most people with cancer, Stacy's diagnosis was not preceded by symptoms. Her mother had already been diagnosed with Stage IV uterin cancer. That prompted Stacy and her siblings to undergo a genetic panel test. It revealed Stacy had the CDH1 mutation, which meant she an 80 percent chance of getting gastric cancer and a 60 percent chance of breast cancer. She had three options but chose to be proactive with a prophylactic total gastrectomy in 2019, a procedure that removed her stomach. It was after the surgery that pathology revealed Stacy had gastric cancer in her removed stomach. After successfully addressing the possibility of stomach cancer, she did the same with breast cancer with a bilateral mastectomy in 2020. Stacy Martin said the toughest part of her cancer experience wasn't the treatment, but what she dealt with upon its completion. She said she had to learn how to eat, and that without a stomach, she had to eat every two hours. While she took snacks with her wherever she went, she had to alternate between snacks and something more substantial, making sure she got enough protein and carbohydrates. Anything she ate had to be completely chewed because she no longer had the gastric juices in her stomach that break down food. The only thing she can't eat are raw oysters because she says they are impossible to chew. Stacy says genetic testing saved her life but admits it is not for everybody because the decision to go forth with such testing is a deeply personal decision because some people don't want to know what the tests could reveal. Despite her cancer journey, Stacy lives a happy life. She resumed her passion of hiking near her home in Chattanooga, Tennessee, and consumption of nuts resulted in her establishing Seahorse Snacks, which she operates out of her home. Additional Resources: Seahorse Snacks: https://www.seahorsesnacks.com No Stomach For Cancer: https://www.nostomachforcancer.org | — | ||||||
| 11/4/25 | ![]() 156: Jonathan Gegerson survived head and neck cancer | salivary duct carcinoma | taxol | herceptin | In 2019, Jonathan Gegerson sought medical attention went he felt a lump on the right side of his neck. After a couple of scans and a biopsy, he was diagnosed with salivary duct carcinoma, a rare form of head and neck cancer. Jonathan survived, but not before enduring 67 sessions of radiation, 12 cycles of chemotherapy (carboplatin, taxol, herceptin) and seven surgeries. He still undergoes a targeted therapy on a monthly basis, and the surgery has affected his speech and his diet, but Jonathan has resumed an active lifestyle that includes skiing and hiking. Jonathan Gegerson thought his health was outstanding. He was an active skier and liked to hike up Colorado's 14ers (mountains whose peaks exceed 14,000 feet), but was perplexed when he discovered a lump on the right side of his neck. He did not waste any time seeking medical attention and went to his primary care physician. She conducted a physical examination and asked if Jonathan had recently undergone a root canal or some dental procedure that could result in an infection. When he said no, the doctor sent Jonathan to an oncologist, who called for a CT scan, a PET scan and a biopsy. That's when he was diagnosed with head and neck cancer, even though at the time doctors could not specify what type of head and neck cancer. His doctor in Colorado said Jonathan would need to undergo surgery, followed by radiation treatment and chemotherapy. When Jonathan learned his care team had no experience with dealing with his type of cancer, he sought a second opinion from MD Anderson in Houston, Texas. The doctors at MD Anderson suggested the same regimen, but Jonathan switched to them because they had experience dealing with salivary duct carcinoma. His care team told him his treatment would result in a tightening of his face and would affect his speech, in addition to his ability to chew and swallow. The chemotherapy regimen included carboplatin, taxol and herceptin. He said the chemo left him weak and tired, especially two days after each round of treatment. This, he said, was very frustrating because he was accustomed to being active. During this time, the best he could do was go on short walks. When Jonathan experienced a recurrence, he was placed on a targeted therapy of kadcyla and herceptin. He eventually achieved survivorship but must continue to be on a monthly targeted therapy of unhertu and herceptin. Jonathan Gegerson says his health is approximately 75 percent of what it was before his diagnosis, but he feels he blessed that he is living, is back to hiking and skiing, and hopes to continue skiing until he is 90 years old. Additional Resources: Jonathan's Book: "Perspective C," available on Amazon and Kindle https://a.co/d/4iW9BQ6 | — | ||||||
| 10/8/25 | ![]() 155: Luke Mutter survived cholangiocarcinoma | systemic chemotherapy | oxaliplatin | folfirinox | trastuzumab | It took two chemotherapy regimens, but Luke Mutter survived a rare form of bile duct cancer. A CT scan found a 14cm tumor in his liver. At that time, his care team told him he had cancer, but it could not identify the type of cancer. He was put on a systemic chemotherapy cocktail of folfirinox and oxaplatin, which attempt to kill the tumor. When that didn't work, Luke learned he was a candidate for a hepatic artery infusion, which included chemo far stronger than his first regimen. Luke has achieved survivorship and is very thankful to be to lead a healthy lifestyle. Considering he was eventually diagnosed with bile duct cancer, his journey in an unlikely place. His feet. He saw a doctor thinking that as an active runner, he had plantar fascilitis. Walking was very painful, as was laying down on his stomach. That is what led to a CT scan, revealing a 14cm tumor in his liver. Luke saw an oncologist and was told he had cancer, but the doctor could not identify what type of cancer. Nonetheless, the doctor said Luke needed to go on a regimen of systemic chemotherapy, which would affect his entire body, a regimen that sought to kill the tumor. The cocktail consisted of oxaliplatin and folfirinox. He received a dosage every two weeks for 18 months. The tumor withstood the chemo, and Luke went to another hospital, where he qualified for a surgical procedure to install a hepatic artery infusion pump. It directed chemotherapy just to the liver at a dose 300 times stronger than the systemic chemotherapy. Luke Mutter achieved survivorship and is thrilled to be back at work as a sales consultant. He also considers a major blessing that after chemotherapy he can taste food, resume exercising and the ability to make his family and friends laugh. By way of advice, he said during his journey, as much as he could, he decided to take charge, by controlling his mindset, exercise, diet and sleep, or as he like to call the group his MEDS. Luke also serves as a mentor to those diagnosed with cholangiocarcinoma. Additional Resources: Support Group: The Cholangiocarcinoma Foundation https://www.cholangiocarcinomafoundation.org | — | ||||||
| 9/20/25 | ![]() 154: Linda Trummer survived mantle cell lymphoma | blastoid variant | doxorubicin | vincristine | cytarabine | It was a stressful journey, but Linda Trummer survived Stage IV mantle cell lymphoma. In 2015, she went to her primary care physician after discovering a lump on her jaw line. That led to a diagnosis of a slow-moving blood cancer, MALtoma. However, further tests revealed a lump under her left arm and the diagnosis was upgraded to Stage IV mantle cell lymphoma, a rare form of blood cancer. She underwent R-Hyper-CVAD, a multi-faceted chemotherapy regimen and just two months later was declared to have No Evidence of Disease. Linda still suffers from the many side effects of her regimen, but is happy to be alive, especially when her prognosis indicated she would only live for another 18 to 24 months. Linda was close to 60 years of age when she first noticed a lump on her jaw line. She initially attributed it to her getting old, but when one day she saw the lump was growing, she sought medical attention. A PET scan showed that she had MALT lymphoma, also known as MALtoma, a cancer associated with the mucosa-associated lymphoid tissue. Linda switched oncologists and the second oncologist called for additional tests. They revealed a lump under her left arm, and she was diagnosed with Stage IV mantle cell lymphoma. Linda was placed on a chemotherapy regimen which included rituximab, doxorubicin, cyclophosphamide, vincristine, dexamethasone and cytarabine. That was followed by six lumbar punctures of methotextrate. Through it all, Linda Tremmer was an active patient. She sought to help other cancer patients on her floor by setting up an arts class. She also wrote poetry and with the aid of a cousin in Oregon, the poetry was set to music, which was played for the patients, who enjoyed getting care from a fellow cancer patient. Linda's regimen led to her being declared NED after two months, but she needed to stay on it and suffered from numerous side effects. She was placed on medication for depression and PTSD, although she says the latter rarely presents a problem. When she was diagnosed, Linda was told she would live another 18 to 24 months, and prepared to die. She sought palliative care and was placed in home hospice. She completed her will, set up cremation and wrote farewell letters to dear friends. But when she got to the 24-month mark, she realized she was still very much alive and started concentrating on living and not dying, which she said was much tougher than it sounds. These days, Linda is happy to be alive, enjoys living with her three dogs and two cats, and advocates for cancer patients through the Leukemia & Lymphoma Society and has a support group on Facebook. By way of advice, she says anyone diagnosed with mantle cell lymphoma should make sure they find an oncologist who knows how to treat mantle cell, which is much easier today than it was in 2015. Additional Resources: Support Group: The Leukemia & Lymphoma Society https://www.lls.org | — | ||||||
Showing 25 of 100
Sponsor Intelligence
Sign in to see which brands sponsor this podcast, their ad offers, and promo codes.
